Markets:

Overview

News

Currencies

International

Treasuries

Edwards Lifesciences (NY:EW)

85.13 +0.55 (+0.65%)

Official Closing Price Updated: 4:00 PM EST, Jan 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Edwards Lifesciences

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

21 22 Next >

Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 10 Years ↗

August 31, 2023

Via Benzinga

Beyond Pills: 3 Non-Pharma Healthcare Stocks for Healthy Gains ↗

August 30, 2023

The demand for healthcare devices and tools are increasing which means their stocks will provide profits for investors.

Via InvestorPlace

Analyst Ratings for Edwards Lifesciences ↗

August 17, 2023

Via Benzinga

(EW) - Analyzing Edwards Lifesciences's Short Interest ↗

August 15, 2023

Via Benzinga

$100 Invested In This Stock 15 Years Ago Would Be Worth $1,600 Today ↗

August 11, 2023

Via Benzinga

Barron's Weekend Stock Picks: PayPal, Nikola And Icahn Enterprises' Challenges ↗

August 05, 2023

Benzinga reviews this weekend's top stories covered by Barron's. Here are the articles investors need to read.

Via Benzinga

Where Edwards Lifesciences Stands With Analysts ↗

August 01, 2023

Via Benzinga

$100 Invested In This Stock 10 Years Ago Would Be Worth $700 Today ↗

July 28, 2023

Via Benzinga

Looking Into Edwards Lifesciences's Recent Short Interest ↗

July 24, 2023

Via Benzinga

Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

July 27, 2023

Gainers Femasys Inc. (NASDAQ: FEMY) gained 54% to $0.55. Femasys reported a notice of allowance for new U.S. patent application covering use of FemBloc for female permanent birth control.

Via Benzinga

US Stocks Buckle Up For Solid Open On Meta's Earnings Boost, Fed Relief — But Analyst Advises Some 'Value-Style' Rebalancing ↗

July 27, 2023

Stocks could be heading to a higher open on Thursday, as traders digest some positive earnings reports and look ahead to another batch of economic data.

Via Benzinga

P/E Ratio Insights for Edwards Lifesciences ↗

July 18, 2023

Via Benzinga

eBay, Barclays, Edwards Lifesciences And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

July 27, 2023

U.S. stock futures traded higher this morning on Thursday. Here are some big stocks recording losses in today’s pre-market trading session. TPI Composites, Inc. (NASDAQ: TPIC) shares declined 20.3% to...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 26, 2023

Via Benzinga

Edwards Lifesciences Sinks Despite An Earnings Beat, Outlook Increase ↗

July 26, 2023

Edwards Lifesciences stock fell after the medtech company reported Q2 earnings.

Via Investor's Business Daily

US Stock Futures Signal Shaky Open On Mixed Tech Earnings: Analyst Expects Fed To Adopt 'Wait-And-See' Rate Approach ↗

July 26, 2023

The market mood could remain cautious until the Fed decision and mixed reaction to tech earnings could also weigh down on sentiment.

Via Benzinga

Where Edwards Lifesciences Stands With Analysts ↗

July 14, 2023

Via Benzinga

Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 15 Years ↗

July 11, 2023

Via Benzinga

Jim Cramer Says This Major Automotive Stock Is Just Too Cheap: 'That's Wrong. I Think You've Got A Winner' ↗

July 20, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Tripadvisor, Inc. (NASDAQ: TRIP) is not good enough, and he prefers Booking Holdings Inc. (NASDAQ: BKNG).

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2023 ↗

July 19, 2023

Via Benzinga

Peering Into Edwards Lifesciences's Recent Short Interest ↗

July 07, 2023

Via Benzinga

Analyst Ratings for Edwards Lifesciences ↗

June 27, 2023

Via Benzinga

Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 10 Years ↗

June 26, 2023

Via Benzinga

$1000 Invested In This Stock 10 Years Ago Would Be Worth $7,400 Today ↗

June 08, 2023

Via Benzinga

Illumina Takes AI to Genomics: Launch of PrimateAI-3D for Accurate Disease Prediction ↗

June 02, 2023

Illumina, Inc. (NASDAQ: ILMN) launched PrimateAI-3D, an artificial intelligence (AI) algorithm that predicts disease-causing genetic mutations in patients.

Via Benzinga

The Latest Analyst Ratings for Edwards Lifesciences ↗

May 30, 2023

Via Benzinga

$100 Invested In This Stock 10 Years Ago Would Be Worth $800 Today ↗

May 24, 2023

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 12, 2023

Via Benzinga

Will Investors Notice Exciting Sign On Edwards Lifesciences's Chart? ↗

May 11, 2023

Via Benzinga

Here's How Much $1000 Invested In Edwards Lifesciences 10 Years Ago Would Be Worth Today ↗

May 09, 2023

Via Benzinga

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.